e-learning
resources
Virtual 2021
05.09.2021
Lung function evaluation and assessment of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Quality of life in COPD - does hyperinflation matter?
I. Tavares Ladeira (Vila Nova de Gaia, Portugal), P. Oliveira (Porto, Portugal), L. Campos (Vila Nova Gaia, Portugal), R. Lima (Vila Nova Gaia, Portugal), M. Guimarães (Vila Nova Gaia, Portugal)
Source:
Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Session:
Lung function evaluation and assessment of airway diseases
Session type:
E-poster
Number:
1063
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Tavares Ladeira (Vila Nova de Gaia, Portugal), P. Oliveira (Porto, Portugal), L. Campos (Vila Nova Gaia, Portugal), R. Lima (Vila Nova Gaia, Portugal), M. Guimarães (Vila Nova Gaia, Portugal). Quality of life in COPD - does hyperinflation matter?. 1063
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Quality of life in obstructive lung diseases
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Health-related quality of life in emphysema due to alpha-1-antitrypsin deficiency
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
Cough is an independent contributor to health-related quality of life impairment in COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
The association between objective CT measures of bronchiectasis and health-related quality of life in COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Quality of life in COPD patients with sarcopenia.
Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases
Year: 2019
Predictive role of mMRC scale on quality of life in COPD patients
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013
Pulmonary rehabilitation: Is it feasible and beneficial in mild COPD?
Source: International Congress 2016 – Latest insights into pulmonary rehabilitation
Year: 2016
Experiences of well-being when living with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Qualitative and quantitative research that contributes to respiratory nursing practice
Year: 2014
Evolution of quality of life (CAT and CCQ) after a COPD exacerbation
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Which are the main determinants of quality-of-life in severe asthma?
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
How to interpret changes in the London chest activity of daily living scale in patients with COPD?
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD
Year: 2013
Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014
Reduction in clinically important deterioration in COPD with aclidinium/formoterol
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Does health related quality of life predict severe physical inactivity in COPD?
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013
Fewer disease problems changes breathing pattern by breathing control exercises in COPD
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016
The effect of pulmonary rehabilitation on health-related quality of life in asthmatic children
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma
Year: 2013
Responsiveness of the clinical COPD questionaire to pulmonary rehabilitation
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Quality of life (QL) depending on psychological disorders (PD) of patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Comorbidities
Year: 2014
Assessing the impact of body mass index on FEV1% and quality of life in asthma patients
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Specific characteristics of selfmanagement are associated with asthma control, quality of life and lung function
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept